nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—pons—epilepsy syndrome	0.0221	0.163	CbGeAlD
Nedocromil—HSP90AA1—ganglion—epilepsy syndrome	0.0113	0.0833	CbGeAlD
Nedocromil—HSP90AA1—hindbrain—epilepsy syndrome	0.0086	0.0632	CbGeAlD
Nedocromil—FPR1—head—epilepsy syndrome	0.00751	0.0552	CbGeAlD
Nedocromil—FPR1—nervous system—epilepsy syndrome	0.00712	0.0523	CbGeAlD
Nedocromil—PTGDR—head—epilepsy syndrome	0.00709	0.0521	CbGeAlD
Nedocromil—FPR1—central nervous system—epilepsy syndrome	0.00686	0.0503	CbGeAlD
Nedocromil—PTGDR—nervous system—epilepsy syndrome	0.00673	0.0494	CbGeAlD
Nedocromil—PTGDR—central nervous system—epilepsy syndrome	0.00647	0.0475	CbGeAlD
Nedocromil—PTGDR—brain—epilepsy syndrome	0.00514	0.0377	CbGeAlD
Nedocromil—HSP90AA1—brainstem—epilepsy syndrome	0.00493	0.0362	CbGeAlD
Nedocromil—HSP90AA1—forebrain—epilepsy syndrome	0.00476	0.0349	CbGeAlD
Nedocromil—HSP90AA1—telencephalon—epilepsy syndrome	0.00438	0.0321	CbGeAlD
Nedocromil—HSP90AA1—medulla oblongata—epilepsy syndrome	0.00344	0.0252	CbGeAlD
Nedocromil—HSP90AA1—midbrain—epilepsy syndrome	0.00314	0.0231	CbGeAlD
Nedocromil—CYSLTR1—head—epilepsy syndrome	0.00314	0.0231	CbGeAlD
Nedocromil—HSP90AA1—spinal cord—epilepsy syndrome	0.00307	0.0225	CbGeAlD
Nedocromil—CYSLTR1—nervous system—epilepsy syndrome	0.00298	0.0219	CbGeAlD
Nedocromil—CYSLTR1—central nervous system—epilepsy syndrome	0.00287	0.021	CbGeAlD
Nedocromil—HSP90AA1—head—epilepsy syndrome	0.00272	0.02	CbGeAlD
Nedocromil—HSP90AA1—nervous system—epilepsy syndrome	0.00258	0.019	CbGeAlD
Nedocromil—HSP90AA1—central nervous system—epilepsy syndrome	0.00249	0.0183	CbGeAlD
Nedocromil—HSP90AA1—cerebellum—epilepsy syndrome	0.00243	0.0179	CbGeAlD
Nedocromil—CYSLTR1—brain—epilepsy syndrome	0.00228	0.0167	CbGeAlD
Nedocromil—HSP90AA1—brain—epilepsy syndrome	0.00197	0.0145	CbGeAlD
Nedocromil—Pharyngitis—Gabapentin—epilepsy syndrome	0.000385	0.000896	CcSEcCtD
Nedocromil—Urticaria—Felbamate—epilepsy syndrome	0.000384	0.000894	CcSEcCtD
Nedocromil—Body temperature increased—Felbamate—epilepsy syndrome	0.000382	0.00089	CcSEcCtD
Nedocromil—Abdominal pain—Felbamate—epilepsy syndrome	0.000382	0.00089	CcSEcCtD
Nedocromil—Vomiting—Acetazolamide—epilepsy syndrome	0.000382	0.00089	CcSEcCtD
Nedocromil—Diarrhoea—Propofol—epilepsy syndrome	0.000382	0.000889	CcSEcCtD
Nedocromil—Tremor—Valproic Acid—epilepsy syndrome	0.000381	0.000888	CcSEcCtD
Nedocromil—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000381	0.000886	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Topiramate—epilepsy syndrome	0.000378	0.000882	CcSEcCtD
Nedocromil—Headache—Acetazolamide—epilepsy syndrome	0.000376	0.000877	CcSEcCtD
Nedocromil—Urticaria—Zonisamide—epilepsy syndrome	0.000376	0.000875	CcSEcCtD
Nedocromil—Body temperature increased—Zonisamide—epilepsy syndrome	0.000374	0.000871	CcSEcCtD
Nedocromil—Abdominal pain—Zonisamide—epilepsy syndrome	0.000374	0.000871	CcSEcCtD
Nedocromil—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000374	0.00087	CcSEcCtD
Nedocromil—Asthenia—Fosphenytoin—epilepsy syndrome	0.000373	0.00087	CcSEcCtD
Nedocromil—Visual impairment—Gabapentin—epilepsy syndrome	0.000373	0.00087	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000373	0.000869	CcSEcCtD
Nedocromil—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000373	0.000868	CcSEcCtD
Nedocromil—Fatigue—Carbamazepine—epilepsy syndrome	0.000373	0.000868	CcSEcCtD
Nedocromil—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000373	0.000868	CcSEcCtD
Nedocromil—Pain—Carbamazepine—epilepsy syndrome	0.00037	0.000861	CcSEcCtD
Nedocromil—Dizziness—Propofol—epilepsy syndrome	0.000369	0.00086	CcSEcCtD
Nedocromil—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000369	0.000859	CcSEcCtD
Nedocromil—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000368	0.000858	CcSEcCtD
Nedocromil—Hypersensitivity—Diazepam—epilepsy syndrome	0.000368	0.000857	CcSEcCtD
Nedocromil—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000368	0.000857	CcSEcCtD
Nedocromil—Pneumonia—Topiramate—epilepsy syndrome	0.000365	0.000851	CcSEcCtD
Nedocromil—Leukopenia—Valproic Acid—epilepsy syndrome	0.000364	0.000848	CcSEcCtD
Nedocromil—Asthenia—Vigabatrin—epilepsy syndrome	0.000364	0.000848	CcSEcCtD
Nedocromil—Urticaria—Clonazepam—epilepsy syndrome	0.000362	0.000844	CcSEcCtD
Nedocromil—Dizziness—Midazolam—epilepsy syndrome	0.000361	0.000841	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000361	0.00084	CcSEcCtD
Nedocromil—Body temperature increased—Clonazepam—epilepsy syndrome	0.00036	0.00084	CcSEcCtD
Nedocromil—Abdominal pain—Clonazepam—epilepsy syndrome	0.00036	0.00084	CcSEcCtD
Nedocromil—Fatigue—Lamotrigine—epilepsy syndrome	0.00036	0.000839	CcSEcCtD
Nedocromil—Dysgeusia—Pregabalin—epilepsy syndrome	0.00036	0.000839	CcSEcCtD
Nedocromil—Urticaria—Phenytoin—epilepsy syndrome	0.00036	0.000838	CcSEcCtD
Nedocromil—Asthenia—Diazepam—epilepsy syndrome	0.000358	0.000835	CcSEcCtD
Nedocromil—Body temperature increased—Phenytoin—epilepsy syndrome	0.000358	0.000834	CcSEcCtD
Nedocromil—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000358	0.000834	CcSEcCtD
Nedocromil—Pain—Lamotrigine—epilepsy syndrome	0.000357	0.000832	CcSEcCtD
Nedocromil—Nausea—Acetazolamide—epilepsy syndrome	0.000357	0.000831	CcSEcCtD
Nedocromil—Dizziness—Levetiracetam—epilepsy syndrome	0.000357	0.000831	CcSEcCtD
Nedocromil—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000356	0.00083	CcSEcCtD
Nedocromil—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000356	0.00083	CcSEcCtD
Nedocromil—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000356	0.000829	CcSEcCtD
Nedocromil—Cough—Valproic Acid—epilepsy syndrome	0.000355	0.000827	CcSEcCtD
Nedocromil—Vomiting—Propofol—epilepsy syndrome	0.000355	0.000827	CcSEcCtD
Nedocromil—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000354	0.000823	CcSEcCtD
Nedocromil—Conjunctivitis—Topiramate—epilepsy syndrome	0.000353	0.000822	CcSEcCtD
Nedocromil—Rash—Propofol—epilepsy syndrome	0.000352	0.00082	CcSEcCtD
Nedocromil—Dermatitis—Propofol—epilepsy syndrome	0.000352	0.000819	CcSEcCtD
Nedocromil—Headache—Propofol—epilepsy syndrome	0.00035	0.000814	CcSEcCtD
Nedocromil—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000349	0.000812	CcSEcCtD
Nedocromil—Vomiting—Midazolam—epilepsy syndrome	0.000347	0.000809	CcSEcCtD
Nedocromil—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000347	0.000808	CcSEcCtD
Nedocromil—Asthenia—Felbamate—epilepsy syndrome	0.000347	0.000808	CcSEcCtD
Nedocromil—Chest pain—Valproic Acid—epilepsy syndrome	0.000346	0.000807	CcSEcCtD
Nedocromil—Tremor—Pregabalin—epilepsy syndrome	0.000345	0.000803	CcSEcCtD
Nedocromil—Rash—Midazolam—epilepsy syndrome	0.000344	0.000802	CcSEcCtD
Nedocromil—Dizziness—Fosphenytoin—epilepsy syndrome	0.000344	0.000802	CcSEcCtD
Nedocromil—Dermatitis—Midazolam—epilepsy syndrome	0.000344	0.000801	CcSEcCtD
Nedocromil—Urticaria—Carbamazepine—epilepsy syndrome	0.000343	0.0008	CcSEcCtD
Nedocromil—Vomiting—Levetiracetam—epilepsy syndrome	0.000343	0.000799	CcSEcCtD
Nedocromil—Headache—Midazolam—epilepsy syndrome	0.000342	0.000797	CcSEcCtD
Nedocromil—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000342	0.000796	CcSEcCtD
Nedocromil—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000342	0.000796	CcSEcCtD
Nedocromil—Diarrhoea—Diazepam—epilepsy syndrome	0.000342	0.000796	CcSEcCtD
Nedocromil—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000342	0.000796	CcSEcCtD
Nedocromil—Sinusitis—Topiramate—epilepsy syndrome	0.000341	0.000793	CcSEcCtD
Nedocromil—Rash—Levetiracetam—epilepsy syndrome	0.00034	0.000792	CcSEcCtD
Nedocromil—Dermatitis—Levetiracetam—epilepsy syndrome	0.00034	0.000791	CcSEcCtD
Nedocromil—Asthenia—Zonisamide—epilepsy syndrome	0.000339	0.000791	CcSEcCtD
Nedocromil—Dry mouth—Valproic Acid—epilepsy syndrome	0.000339	0.000789	CcSEcCtD
Nedocromil—Headache—Levetiracetam—epilepsy syndrome	0.000338	0.000787	CcSEcCtD
Nedocromil—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000336	0.000782	CcSEcCtD
Nedocromil—Dizziness—Vigabatrin—epilepsy syndrome	0.000335	0.000781	CcSEcCtD
Nedocromil—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000334	0.000777	CcSEcCtD
Nedocromil—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000332	0.000773	CcSEcCtD
Nedocromil—Urticaria—Lamotrigine—epilepsy syndrome	0.000332	0.000773	CcSEcCtD
Nedocromil—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000332	0.000773	CcSEcCtD
Nedocromil—Nausea—Propofol—epilepsy syndrome	0.000332	0.000772	CcSEcCtD
Nedocromil—Vomiting—Fosphenytoin—epilepsy syndrome	0.000331	0.000771	CcSEcCtD
Nedocromil—Diarrhoea—Felbamate—epilepsy syndrome	0.000331	0.00077	CcSEcCtD
Nedocromil—Abdominal pain—Lamotrigine—epilepsy syndrome	0.00033	0.000769	CcSEcCtD
Nedocromil—Body temperature increased—Lamotrigine—epilepsy syndrome	0.00033	0.000769	CcSEcCtD
Nedocromil—Dysgeusia—Gabapentin—epilepsy syndrome	0.00033	0.000769	CcSEcCtD
Nedocromil—Dizziness—Diazepam—epilepsy syndrome	0.00033	0.000769	CcSEcCtD
Nedocromil—Leukopenia—Pregabalin—epilepsy syndrome	0.000329	0.000767	CcSEcCtD
Nedocromil—Rash—Fosphenytoin—epilepsy syndrome	0.000328	0.000764	CcSEcCtD
Nedocromil—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000328	0.000764	CcSEcCtD
Nedocromil—Asthenia—Clonazepam—epilepsy syndrome	0.000327	0.000762	CcSEcCtD
Nedocromil—Rhinitis—Topiramate—epilepsy syndrome	0.000327	0.000761	CcSEcCtD
Nedocromil—Headache—Fosphenytoin—epilepsy syndrome	0.000326	0.000759	CcSEcCtD
Nedocromil—Asthenia—Phenytoin—epilepsy syndrome	0.000325	0.000757	CcSEcCtD
Nedocromil—Nausea—Midazolam—epilepsy syndrome	0.000324	0.000755	CcSEcCtD
Nedocromil—Diarrhoea—Zonisamide—epilepsy syndrome	0.000324	0.000754	CcSEcCtD
Nedocromil—Pharyngitis—Topiramate—epilepsy syndrome	0.000324	0.000754	CcSEcCtD
Nedocromil—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000323	0.000753	CcSEcCtD
Nedocromil—Vomiting—Vigabatrin—epilepsy syndrome	0.000323	0.000751	CcSEcCtD
Nedocromil—Cough—Pregabalin—epilepsy syndrome	0.000321	0.000748	CcSEcCtD
Nedocromil—Nausea—Levetiracetam—epilepsy syndrome	0.00032	0.000746	CcSEcCtD
Nedocromil—Rash—Vigabatrin—epilepsy syndrome	0.00032	0.000745	CcSEcCtD
Nedocromil—Dizziness—Felbamate—epilepsy syndrome	0.00032	0.000744	CcSEcCtD
Nedocromil—Dermatitis—Vigabatrin—epilepsy syndrome	0.00032	0.000744	CcSEcCtD
Nedocromil—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000319	0.000742	CcSEcCtD
Nedocromil—Headache—Vigabatrin—epilepsy syndrome	0.000318	0.00074	CcSEcCtD
Nedocromil—Vomiting—Diazepam—epilepsy syndrome	0.000318	0.00074	CcSEcCtD
Nedocromil—Tremor—Gabapentin—epilepsy syndrome	0.000316	0.000736	CcSEcCtD
Nedocromil—Rash—Diazepam—epilepsy syndrome	0.000315	0.000733	CcSEcCtD
Nedocromil—Dermatitis—Diazepam—epilepsy syndrome	0.000315	0.000733	CcSEcCtD
Nedocromil—Visual impairment—Topiramate—epilepsy syndrome	0.000314	0.000732	CcSEcCtD
Nedocromil—Chest pain—Pregabalin—epilepsy syndrome	0.000313	0.000729	CcSEcCtD
Nedocromil—Dizziness—Zonisamide—epilepsy syndrome	0.000313	0.000729	CcSEcCtD
Nedocromil—Headache—Diazepam—epilepsy syndrome	0.000313	0.000729	CcSEcCtD
Nedocromil—Diarrhoea—Clonazepam—epilepsy syndrome	0.000312	0.000727	CcSEcCtD
Nedocromil—Asthenia—Carbamazepine—epilepsy syndrome	0.00031	0.000723	CcSEcCtD
Nedocromil—Diarrhoea—Phenytoin—epilepsy syndrome	0.00031	0.000722	CcSEcCtD
Nedocromil—Nausea—Fosphenytoin—epilepsy syndrome	0.000309	0.00072	CcSEcCtD
Nedocromil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000308	0.000718	CcSEcCtD
Nedocromil—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000308	0.000717	CcSEcCtD
Nedocromil—Vomiting—Felbamate—epilepsy syndrome	0.000307	0.000716	CcSEcCtD
Nedocromil—Dry mouth—Pregabalin—epilepsy syndrome	0.000306	0.000713	CcSEcCtD
Nedocromil—Rash—Felbamate—epilepsy syndrome	0.000305	0.00071	CcSEcCtD
Nedocromil—Dermatitis—Felbamate—epilepsy syndrome	0.000304	0.000709	CcSEcCtD
Nedocromil—Headache—Felbamate—epilepsy syndrome	0.000303	0.000705	CcSEcCtD
Nedocromil—Leukopenia—Gabapentin—epilepsy syndrome	0.000302	0.000703	CcSEcCtD
Nedocromil—Dizziness—Clonazepam—epilepsy syndrome	0.000302	0.000702	CcSEcCtD
Nedocromil—Nausea—Vigabatrin—epilepsy syndrome	0.000301	0.000702	CcSEcCtD
Nedocromil—Vomiting—Zonisamide—epilepsy syndrome	0.000301	0.000701	CcSEcCtD
Nedocromil—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.0003	0.000699	CcSEcCtD
Nedocromil—Asthenia—Lamotrigine—epilepsy syndrome	0.0003	0.000698	CcSEcCtD
Nedocromil—Dizziness—Phenytoin—epilepsy syndrome	0.0003	0.000698	CcSEcCtD
Nedocromil—Rash—Zonisamide—epilepsy syndrome	0.000298	0.000695	CcSEcCtD
Nedocromil—Dermatitis—Zonisamide—epilepsy syndrome	0.000298	0.000694	CcSEcCtD
Nedocromil—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000298	0.000694	CcSEcCtD
Nedocromil—Nausea—Diazepam—epilepsy syndrome	0.000297	0.000691	CcSEcCtD
Nedocromil—Headache—Zonisamide—epilepsy syndrome	0.000296	0.00069	CcSEcCtD
Nedocromil—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000296	0.000689	CcSEcCtD
Nedocromil—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000296	0.000689	CcSEcCtD
Nedocromil—Cough—Gabapentin—epilepsy syndrome	0.000294	0.000685	CcSEcCtD
Nedocromil—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000292	0.000681	CcSEcCtD
Nedocromil—Vomiting—Clonazepam—epilepsy syndrome	0.00029	0.000675	CcSEcCtD
Nedocromil—Vomiting—Phenytoin—epilepsy syndrome	0.000288	0.000671	CcSEcCtD
Nedocromil—Rash—Clonazepam—epilepsy syndrome	0.000288	0.00067	CcSEcCtD
Nedocromil—Dermatitis—Clonazepam—epilepsy syndrome	0.000287	0.000669	CcSEcCtD
Nedocromil—Chest pain—Gabapentin—epilepsy syndrome	0.000287	0.000669	CcSEcCtD
Nedocromil—Nausea—Felbamate—epilepsy syndrome	0.000287	0.000669	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000287	0.000668	CcSEcCtD
Nedocromil—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000286	0.000667	CcSEcCtD
Nedocromil—Fatigue—Valproic Acid—epilepsy syndrome	0.000286	0.000667	CcSEcCtD
Nedocromil—Dizziness—Carbamazepine—epilepsy syndrome	0.000286	0.000666	CcSEcCtD
Nedocromil—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000286	0.000666	CcSEcCtD
Nedocromil—Headache—Clonazepam—epilepsy syndrome	0.000286	0.000665	CcSEcCtD
Nedocromil—Rash—Phenytoin—epilepsy syndrome	0.000286	0.000665	CcSEcCtD
Nedocromil—Dermatitis—Phenytoin—epilepsy syndrome	0.000285	0.000665	CcSEcCtD
Nedocromil—Rash—Oxcarbazepine—epilepsy syndrome	0.000284	0.000662	CcSEcCtD
Nedocromil—Pain—Valproic Acid—epilepsy syndrome	0.000284	0.000661	CcSEcCtD
Nedocromil—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000284	0.000661	CcSEcCtD
Nedocromil—Headache—Phenytoin—epilepsy syndrome	0.000284	0.000661	CcSEcCtD
Nedocromil—Headache—Oxcarbazepine—epilepsy syndrome	0.000282	0.000657	CcSEcCtD
Nedocromil—Nausea—Zonisamide—epilepsy syndrome	0.000281	0.000655	CcSEcCtD
Nedocromil—Dry mouth—Gabapentin—epilepsy syndrome	0.000281	0.000654	CcSEcCtD
Nedocromil—Dysgeusia—Topiramate—epilepsy syndrome	0.000278	0.000647	CcSEcCtD
Nedocromil—Dizziness—Lamotrigine—epilepsy syndrome	0.000276	0.000644	CcSEcCtD
Nedocromil—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000275	0.000641	CcSEcCtD
Nedocromil—Vomiting—Carbamazepine—epilepsy syndrome	0.000275	0.00064	CcSEcCtD
Nedocromil—Rash—Carbamazepine—epilepsy syndrome	0.000273	0.000635	CcSEcCtD
Nedocromil—Dermatitis—Carbamazepine—epilepsy syndrome	0.000272	0.000634	CcSEcCtD
Nedocromil—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000272	0.000632	CcSEcCtD
Nedocromil—Nausea—Clonazepam—epilepsy syndrome	0.000271	0.000631	CcSEcCtD
Nedocromil—Headache—Carbamazepine—epilepsy syndrome	0.000271	0.000631	CcSEcCtD
Nedocromil—Nausea—Phenytoin—epilepsy syndrome	0.000269	0.000627	CcSEcCtD
Nedocromil—Dyspnoea—Pregabalin—epilepsy syndrome	0.000268	0.000623	CcSEcCtD
Nedocromil—Nausea—Oxcarbazepine—epilepsy syndrome	0.000268	0.000623	CcSEcCtD
Nedocromil—Tremor—Topiramate—epilepsy syndrome	0.000266	0.000619	CcSEcCtD
Nedocromil—Vomiting—Lamotrigine—epilepsy syndrome	0.000266	0.000619	CcSEcCtD
Nedocromil—Urticaria—Valproic Acid—epilepsy syndrome	0.000264	0.000614	CcSEcCtD
Nedocromil—Rash—Lamotrigine—epilepsy syndrome	0.000263	0.000614	CcSEcCtD
Nedocromil—Dermatitis—Lamotrigine—epilepsy syndrome	0.000263	0.000613	CcSEcCtD
Nedocromil—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000262	0.000611	CcSEcCtD
Nedocromil—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000262	0.000611	CcSEcCtD
Nedocromil—Headache—Lamotrigine—epilepsy syndrome	0.000262	0.00061	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000259	0.000604	CcSEcCtD
Nedocromil—Fatigue—Pregabalin—epilepsy syndrome	0.000259	0.000603	CcSEcCtD
Nedocromil—Nausea—Carbamazepine—epilepsy syndrome	0.000257	0.000598	CcSEcCtD
Nedocromil—Pain—Pregabalin—epilepsy syndrome	0.000257	0.000598	CcSEcCtD
Nedocromil—Leukopenia—Topiramate—epilepsy syndrome	0.000254	0.000592	CcSEcCtD
Nedocromil—Nausea—Lamotrigine—epilepsy syndrome	0.000248	0.000578	CcSEcCtD
Nedocromil—Cough—Topiramate—epilepsy syndrome	0.000248	0.000577	CcSEcCtD
Nedocromil—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000245	0.000572	CcSEcCtD
Nedocromil—Dyspnoea—Gabapentin—epilepsy syndrome	0.000245	0.000572	CcSEcCtD
Nedocromil—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000245	0.00057	CcSEcCtD
Nedocromil—Dyspepsia—Gabapentin—epilepsy syndrome	0.000242	0.000564	CcSEcCtD
Nedocromil—Chest pain—Topiramate—epilepsy syndrome	0.000242	0.000563	CcSEcCtD
Nedocromil—Urticaria—Pregabalin—epilepsy syndrome	0.000238	0.000555	CcSEcCtD
Nedocromil—Asthenia—Valproic Acid—epilepsy syndrome	0.000238	0.000555	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000238	0.000553	CcSEcCtD
Nedocromil—Fatigue—Gabapentin—epilepsy syndrome	0.000237	0.000553	CcSEcCtD
Nedocromil—Abdominal pain—Pregabalin—epilepsy syndrome	0.000237	0.000553	CcSEcCtD
Nedocromil—Body temperature increased—Pregabalin—epilepsy syndrome	0.000237	0.000553	CcSEcCtD
Nedocromil—Dry mouth—Topiramate—epilepsy syndrome	0.000236	0.00055	CcSEcCtD
Nedocromil—Pain—Gabapentin—epilepsy syndrome	0.000235	0.000548	CcSEcCtD
Nedocromil—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000227	0.000529	CcSEcCtD
Nedocromil—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000225	0.000524	CcSEcCtD
Nedocromil—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000221	0.000515	CcSEcCtD
Nedocromil—Dizziness—Valproic Acid—epilepsy syndrome	0.00022	0.000511	CcSEcCtD
Nedocromil—Urticaria—Gabapentin—epilepsy syndrome	0.000219	0.000509	CcSEcCtD
Nedocromil—Body temperature increased—Gabapentin—epilepsy syndrome	0.000218	0.000507	CcSEcCtD
Nedocromil—Abdominal pain—Gabapentin—epilepsy syndrome	0.000218	0.000507	CcSEcCtD
Nedocromil—Asthenia—Pregabalin—epilepsy syndrome	0.000215	0.000502	CcSEcCtD
Nedocromil—Vomiting—Valproic Acid—epilepsy syndrome	0.000211	0.000492	CcSEcCtD
Nedocromil—Rash—Valproic Acid—epilepsy syndrome	0.000209	0.000488	CcSEcCtD
Nedocromil—Dermatitis—Valproic Acid—epilepsy syndrome	0.000209	0.000487	CcSEcCtD
Nedocromil—Headache—Valproic Acid—epilepsy syndrome	0.000208	0.000484	CcSEcCtD
Nedocromil—Dyspnoea—Topiramate—epilepsy syndrome	0.000206	0.000481	CcSEcCtD
Nedocromil—Diarrhoea—Pregabalin—epilepsy syndrome	0.000205	0.000478	CcSEcCtD
Nedocromil—Dyspepsia—Topiramate—epilepsy syndrome	0.000204	0.000475	CcSEcCtD
Nedocromil—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000203	0.000472	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.0002	0.000466	CcSEcCtD
Nedocromil—Fatigue—Topiramate—epilepsy syndrome	0.0002	0.000465	CcSEcCtD
Nedocromil—Dizziness—Pregabalin—epilepsy syndrome	0.000199	0.000462	CcSEcCtD
Nedocromil—Pain—Topiramate—epilepsy syndrome	0.000198	0.000461	CcSEcCtD
Nedocromil—Asthenia—Gabapentin—epilepsy syndrome	0.000197	0.00046	CcSEcCtD
Nedocromil—Nausea—Valproic Acid—epilepsy syndrome	0.000197	0.000459	CcSEcCtD
Nedocromil—Vomiting—Pregabalin—epilepsy syndrome	0.000191	0.000445	CcSEcCtD
Nedocromil—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000189	0.000441	CcSEcCtD
Nedocromil—Rash—Pregabalin—epilepsy syndrome	0.000189	0.000441	CcSEcCtD
Nedocromil—Dermatitis—Pregabalin—epilepsy syndrome	0.000189	0.00044	CcSEcCtD
Nedocromil—Diarrhoea—Gabapentin—epilepsy syndrome	0.000188	0.000439	CcSEcCtD
Nedocromil—Headache—Pregabalin—epilepsy syndrome	0.000188	0.000438	CcSEcCtD
Nedocromil—Urticaria—Topiramate—epilepsy syndrome	0.000184	0.000428	CcSEcCtD
Nedocromil—Body temperature increased—Topiramate—epilepsy syndrome	0.000183	0.000426	CcSEcCtD
Nedocromil—Abdominal pain—Topiramate—epilepsy syndrome	0.000183	0.000426	CcSEcCtD
Nedocromil—Dizziness—Gabapentin—epilepsy syndrome	0.000182	0.000424	CcSEcCtD
Nedocromil—Nausea—Pregabalin—epilepsy syndrome	0.000178	0.000415	CcSEcCtD
Nedocromil—Vomiting—Gabapentin—epilepsy syndrome	0.000175	0.000408	CcSEcCtD
Nedocromil—Rash—Gabapentin—epilepsy syndrome	0.000174	0.000404	CcSEcCtD
Nedocromil—Dermatitis—Gabapentin—epilepsy syndrome	0.000173	0.000404	CcSEcCtD
Nedocromil—Headache—Gabapentin—epilepsy syndrome	0.000172	0.000402	CcSEcCtD
Nedocromil—Hypersensitivity—Topiramate—epilepsy syndrome	0.000171	0.000397	CcSEcCtD
Nedocromil—Asthenia—Topiramate—epilepsy syndrome	0.000166	0.000387	CcSEcCtD
Nedocromil—Nausea—Gabapentin—epilepsy syndrome	0.000164	0.000381	CcSEcCtD
Nedocromil—Diarrhoea—Topiramate—epilepsy syndrome	0.000158	0.000369	CcSEcCtD
Nedocromil—Dizziness—Topiramate—epilepsy syndrome	0.000153	0.000357	CcSEcCtD
Nedocromil—Vomiting—Topiramate—epilepsy syndrome	0.000147	0.000343	CcSEcCtD
Nedocromil—Rash—Topiramate—epilepsy syndrome	0.000146	0.00034	CcSEcCtD
Nedocromil—Dermatitis—Topiramate—epilepsy syndrome	0.000146	0.00034	CcSEcCtD
Nedocromil—Headache—Topiramate—epilepsy syndrome	0.000145	0.000338	CcSEcCtD
Nedocromil—Nausea—Topiramate—epilepsy syndrome	0.000138	0.00032	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—PTK2B—epilepsy syndrome	3.89e-05	8.94e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PRKCB—epilepsy syndrome	3.84e-05	8.84e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AGT—epilepsy syndrome	3.83e-05	8.81e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6ST—epilepsy syndrome	3.83e-05	8.81e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ABCG2—epilepsy syndrome	3.82e-05	8.78e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FYN—epilepsy syndrome	3.8e-05	8.75e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—H2AFX—epilepsy syndrome	3.79e-05	8.71e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCR2—epilepsy syndrome	3.78e-05	8.7e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NTRK2—epilepsy syndrome	3.78e-05	8.7e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MEF2C—epilepsy syndrome	3.78e-05	8.7e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SST—epilepsy syndrome	3.78e-05	8.7e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CX3CR1—epilepsy syndrome	3.75e-05	8.64e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DUSP6—epilepsy syndrome	3.75e-05	8.62e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP2C19—epilepsy syndrome	3.72e-05	8.56e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—SRC—epilepsy syndrome	3.71e-05	8.55e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADRA2A—epilepsy syndrome	3.7e-05	8.51e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP11A1—epilepsy syndrome	3.7e-05	8.51e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PLAT—epilepsy syndrome	3.68e-05	8.48e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BDKRB1—epilepsy syndrome	3.68e-05	8.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CX3CL1—epilepsy syndrome	3.68e-05	8.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CHRM2—epilepsy syndrome	3.68e-05	8.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—AKT1—epilepsy syndrome	3.68e-05	8.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HBEGF—epilepsy syndrome	3.67e-05	8.44e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.65e-05	8.41e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—FOS—epilepsy syndrome	3.63e-05	8.36e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—FGF2—epilepsy syndrome	3.63e-05	8.36e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—POMC—epilepsy syndrome	3.62e-05	8.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—VEGFA—epilepsy syndrome	3.62e-05	8.33e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NGF—epilepsy syndrome	3.61e-05	8.31e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SLC2A1—epilepsy syndrome	3.6e-05	8.29e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT3—epilepsy syndrome	3.6e-05	8.29e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GABBR1—epilepsy syndrome	3.58e-05	8.24e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—JUNB—epilepsy syndrome	3.58e-05	8.23e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—BDKRB2—epilepsy syndrome	3.55e-05	8.18e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL12—epilepsy syndrome	3.55e-05	8.18e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CASP8—epilepsy syndrome	3.55e-05	8.17e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS1—epilepsy syndrome	3.55e-05	8.17e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—POMC—epilepsy syndrome	3.55e-05	8.17e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL2—epilepsy syndrome	3.55e-05	8.16e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PRKCB—epilepsy syndrome	3.54e-05	8.14e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6ST—epilepsy syndrome	3.52e-05	8.11e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCR5—epilepsy syndrome	3.51e-05	8.09e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—POMC—epilepsy syndrome	3.5e-05	8.05e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—JUNB—epilepsy syndrome	3.49e-05	8.03e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CNR1—epilepsy syndrome	3.49e-05	8.03e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PLCB1—epilepsy syndrome	3.48e-05	8e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HTR2A—epilepsy syndrome	3.44e-05	7.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRH3—epilepsy syndrome	3.43e-05	7.9e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL2—epilepsy syndrome	3.42e-05	7.88e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR7—epilepsy syndrome	3.4e-05	7.83e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HBEGF—epilepsy syndrome	3.39e-05	7.79e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—OPRM1—epilepsy syndrome	3.38e-05	7.78e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—RELA—epilepsy syndrome	3.37e-05	7.76e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP2D6—epilepsy syndrome	3.34e-05	7.68e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—S100B—epilepsy syndrome	3.33e-05	7.65e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT3—epilepsy syndrome	3.32e-05	7.65e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HBEGF—epilepsy syndrome	3.3e-05	7.6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—SOCS3—epilepsy syndrome	3.29e-05	7.58e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDC42—epilepsy syndrome	3.28e-05	7.56e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TSC2—epilepsy syndrome	3.27e-05	7.52e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AGT—epilepsy syndrome	3.26e-05	7.51e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ADAM10—epilepsy syndrome	3.25e-05	7.47e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT3—epilepsy syndrome	3.24e-05	7.46e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—POMC—epilepsy syndrome	3.22e-05	7.42e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—FGF2—epilepsy syndrome	3.21e-05	7.38e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—FGF2—epilepsy syndrome	3.2e-05	7.37e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—APOE—epilepsy syndrome	3.2e-05	7.36e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR3—epilepsy syndrome	3.19e-05	7.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ADRA2A—epilepsy syndrome	3.17e-05	7.31e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADAM10—epilepsy syndrome	3.17e-05	7.29e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—BCHE—epilepsy syndrome	3.16e-05	7.28e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL2—epilepsy syndrome	3.15e-05	7.26e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KDR—epilepsy syndrome	3.13e-05	7.21e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NPY—epilepsy syndrome	3.11e-05	7.16e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ATP2A2—epilepsy syndrome	3.11e-05	7.16e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—FGF2—epilepsy syndrome	3.09e-05	7.12e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—BCL2—epilepsy syndrome	3.05e-05	7.01e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CDC42—epilepsy syndrome	3.03e-05	6.98e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SLC2A1—epilepsy syndrome	3.02e-05	6.94e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PRKCB—epilepsy syndrome	3.01e-05	6.94e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6ST—epilepsy syndrome	3e-05	6.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL18—epilepsy syndrome	3e-05	6.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HSPB1—epilepsy syndrome	3e-05	6.9e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—OXT—epilepsy syndrome	3e-05	6.9e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CRH—epilepsy syndrome	3e-05	6.9e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL2—epilepsy syndrome	3e-05	6.9e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL3—epilepsy syndrome	3e-05	6.9e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—S100B—epilepsy syndrome	3e-05	6.89e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PLCB1—epilepsy syndrome	2.98e-05	6.87e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—RELA—epilepsy syndrome	2.98e-05	6.85e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—RELA—epilepsy syndrome	2.97e-05	6.85e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TH—epilepsy syndrome	2.97e-05	6.84e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SOCS3—epilepsy syndrome	2.97e-05	6.83e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CDC42—epilepsy syndrome	2.96e-05	6.81e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FYN—epilepsy syndrome	2.92e-05	6.73e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MTOR—epilepsy syndrome	2.92e-05	6.72e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MTOR—epilepsy syndrome	2.92e-05	6.71e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MEF2C—epilepsy syndrome	2.91e-05	6.69e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MMP9—epilepsy syndrome	2.87e-05	6.62e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—RELA—epilepsy syndrome	2.87e-05	6.61e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AVP—epilepsy syndrome	2.86e-05	6.59e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MTOR—epilepsy syndrome	2.82e-05	6.48e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—YWHAZ—epilepsy syndrome	2.81e-05	6.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TSC1—epilepsy syndrome	2.79e-05	6.42e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTK2B—epilepsy syndrome	2.79e-05	6.42e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HES1—epilepsy syndrome	2.78e-05	6.39e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—POMC—epilepsy syndrome	2.75e-05	6.32e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NTRK2—epilepsy syndrome	2.71e-05	6.24e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR2—epilepsy syndrome	2.71e-05	6.24e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SST—epilepsy syndrome	2.71e-05	6.24e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HES1—epilepsy syndrome	2.71e-05	6.23e-05	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.71e-05	6.23e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FYN—epilepsy syndrome	2.7e-05	6.21e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—H2AFX—epilepsy syndrome	2.69e-05	6.19e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DUSP6—epilepsy syndrome	2.69e-05	6.19e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL2—epilepsy syndrome	2.69e-05	6.18e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CASP3—epilepsy syndrome	2.68e-05	6.17e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.65e-05	6.11e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—SRC—epilepsy syndrome	2.65e-05	6.1e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PLAT—epilepsy syndrome	2.64e-05	6.08e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FYN—epilepsy syndrome	2.63e-05	6.06e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—H2AFX—epilepsy syndrome	2.62e-05	6.04e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MEF2C—epilepsy syndrome	2.62e-05	6.03e-05	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—epilepsy syndrome	2.62e-05	6.02e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—JUN—epilepsy syndrome	2.61e-05	6.01e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—JUN—epilepsy syndrome	2.61e-05	6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—YWHAZ—epilepsy syndrome	2.6e-05	5.97e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CASP3—epilepsy syndrome	2.59e-05	5.96e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—epilepsy syndrome	2.58e-05	5.94e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BDKRB2—epilepsy syndrome	2.55e-05	5.87e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL12—epilepsy syndrome	2.55e-05	5.87e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MMP9—epilepsy syndrome	2.54e-05	5.84e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.53e-05	5.83e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—JUN—epilepsy syndrome	2.52e-05	5.79e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TSC2—epilepsy syndrome	2.51e-05	5.79e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CRP—epilepsy syndrome	2.51e-05	5.79e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NGF—epilepsy syndrome	2.5e-05	5.76e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—JUNB—epilepsy syndrome	2.5e-05	5.76e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CNR1—epilepsy syndrome	2.5e-05	5.76e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CCR5—epilepsy syndrome	2.5e-05	5.75e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PLCB1—epilepsy syndrome	2.49e-05	5.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HMOX1—epilepsy syndrome	2.48e-05	5.71e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—epilepsy syndrome	2.46e-05	5.66e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MMP9—epilepsy syndrome	2.45e-05	5.64e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CAT—epilepsy syndrome	2.45e-05	5.63e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR7—epilepsy syndrome	2.44e-05	5.62e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCR5—epilepsy syndrome	2.44e-05	5.61e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FGF2—epilepsy syndrome	2.43e-05	5.59e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR2A—epilepsy syndrome	2.38e-05	5.49e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ABCB1—epilepsy syndrome	2.38e-05	5.48e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—epilepsy syndrome	2.37e-05	5.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HBEGF—epilepsy syndrome	2.37e-05	5.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—SRC—epilepsy syndrome	2.34e-05	5.39e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SRC—epilepsy syndrome	2.34e-05	5.38e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT3—epilepsy syndrome	2.33e-05	5.36e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TSC2—epilepsy syndrome	2.32e-05	5.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PRKCB—epilepsy syndrome	2.32e-05	5.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6ST—epilepsy syndrome	2.31e-05	5.32e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—epilepsy syndrome	2.28e-05	5.24e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADAM10—epilepsy syndrome	2.27e-05	5.23e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOE—epilepsy syndrome	2.27e-05	5.23e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TSC2—epilepsy syndrome	2.26e-05	5.21e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AGT—epilepsy syndrome	2.26e-05	5.2e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SRC—epilepsy syndrome	2.26e-05	5.2e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RELA—epilepsy syndrome	2.25e-05	5.19e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOE—epilepsy syndrome	2.22e-05	5.1e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GPX1—epilepsy syndrome	2.21e-05	5.1e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—epilepsy syndrome	2.21e-05	5.09e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MTOR—epilepsy syndrome	2.21e-05	5.09e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—epilepsy syndrome	2.2e-05	5.06e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KDR—epilepsy syndrome	2.17e-05	5e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—S100B—epilepsy syndrome	2.15e-05	4.95e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6ST—epilepsy syndrome	2.13e-05	4.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SOCS3—epilepsy syndrome	2.13e-05	4.9e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDC42—epilepsy syndrome	2.12e-05	4.89e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FOS—epilepsy syndrome	2.12e-05	4.87e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS2—epilepsy syndrome	2.12e-05	4.87e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PRKCB—epilepsy syndrome	2.09e-05	4.81e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6ST—epilepsy syndrome	2.08e-05	4.79e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CASP8—epilepsy syndrome	2.07e-05	4.76e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AVP—epilepsy syndrome	2.06e-05	4.73e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.05e-05	4.72e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CASP3—epilepsy syndrome	2.03e-05	4.68e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—JUN—epilepsy syndrome	1.97e-05	4.55e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HES1—epilepsy syndrome	1.94e-05	4.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AGT—epilepsy syndrome	1.94e-05	4.47e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MMP9—epilepsy syndrome	1.92e-05	4.42e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—POMC—epilepsy syndrome	1.9e-05	4.38e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOE—epilepsy syndrome	1.9e-05	4.38e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FYN—epilepsy syndrome	1.89e-05	4.35e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—H2AFX—epilepsy syndrome	1.88e-05	4.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MEF2C—epilepsy syndrome	1.88e-05	4.33e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FGF2—epilepsy syndrome	1.87e-05	4.3e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—epilepsy syndrome	1.86e-05	4.29e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL2—epilepsy syndrome	1.86e-05	4.29e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.82e-05	4.18e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NGF—epilepsy syndrome	1.8e-05	4.14e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BCL2—epilepsy syndrome	1.77e-05	4.08e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SRC—epilepsy syndrome	1.77e-05	4.08e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR5—epilepsy syndrome	1.75e-05	4.02e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—RELA—epilepsy syndrome	1.73e-05	3.99e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—epilepsy syndrome	1.73e-05	3.97e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGF2—epilepsy syndrome	1.73e-05	3.97e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR2A—epilepsy syndrome	1.71e-05	3.94e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MTOR—epilepsy syndrome	1.7e-05	3.92e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGF2—epilepsy syndrome	1.68e-05	3.87e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—epilepsy syndrome	1.65e-05	3.79e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—POMC—epilepsy syndrome	1.63e-05	3.76e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TSC2—epilepsy syndrome	1.63e-05	3.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AGT—epilepsy syndrome	1.62e-05	3.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOE—epilepsy syndrome	1.59e-05	3.66e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MTOR—epilepsy syndrome	1.57e-05	3.61e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—epilepsy syndrome	1.57e-05	3.61e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RELA—epilepsy syndrome	1.56e-05	3.6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KDR—epilepsy syndrome	1.56e-05	3.59e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—epilepsy syndrome	1.56e-05	3.58e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MTOR—epilepsy syndrome	1.53e-05	3.53e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—JUN—epilepsy syndrome	1.52e-05	3.5e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRKCB—epilepsy syndrome	1.5e-05	3.45e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6ST—epilepsy syndrome	1.49e-05	3.44e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALB—epilepsy syndrome	1.49e-05	3.43e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—epilepsy syndrome	1.45e-05	3.35e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—epilepsy syndrome	1.45e-05	3.34e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.42e-05	3.27e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CASP3—epilepsy syndrome	1.41e-05	3.24e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—epilepsy syndrome	1.4e-05	3.23e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—JUN—epilepsy syndrome	1.37e-05	3.15e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—POMC—epilepsy syndrome	1.37e-05	3.14e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—SRC—epilepsy syndrome	1.36e-05	3.14e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL2—epilepsy syndrome	1.34e-05	3.08e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP9—epilepsy syndrome	1.33e-05	3.07e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—epilepsy syndrome	1.3e-05	3e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—epilepsy syndrome	1.29e-05	2.97e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SRC—epilepsy syndrome	1.26e-05	2.9e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SRC—epilepsy syndrome	1.23e-05	2.83e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGF2—epilepsy syndrome	1.21e-05	2.78e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—epilepsy syndrome	1.2e-05	2.75e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RELA—epilepsy syndrome	1.12e-05	2.58e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—epilepsy syndrome	1.1e-05	2.53e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MTOR—epilepsy syndrome	1.1e-05	2.53e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CASP3—epilepsy syndrome	1.01e-05	2.33e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—JUN—epilepsy syndrome	9.83e-06	2.26e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP9—epilepsy syndrome	9.56e-06	2.2e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SRC—epilepsy syndrome	8.81e-06	2.03e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—epilepsy syndrome	8.58e-06	1.98e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—epilepsy syndrome	8.47e-06	1.95e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—epilepsy syndrome	7.82e-06	1.8e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—epilepsy syndrome	7.63e-06	1.76e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—epilepsy syndrome	6.55e-06	1.51e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—epilepsy syndrome	5.48e-06	1.26e-05	CbGpPWpGaD
